UK, India sign deal to support R&D, innovation projects

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Quantum Computing Advances Make Way for Lifesaving Therapies

The fact is that there is something very profoundly...

Resistance-Evasive Antibiotic for Genes-Free Clinics

In a startling figure, multidrug-resistant bacteria kill almost 5...

Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma

In order to treat multiple myeloma in adults, Sarclisa...

The Technology Strategy Board (TSB) in the UK and the Indian government’s Department of Science and Technology have signed ‘Programme of Co-operation’ deal to support joint, collaborative research and development (R&D) and innovation projects in key areas, including energy and healthcare.

Under the agreement, the TSB and the Indian Global Innovation and Technology Alliance (GITA), sponsored by the Indian government, support the UK and Indian businesses and academics over a three year period.

The TSB will contribute £5m to the project, which is the first international partnership by the UK public body outside Europe.

TSB chief executive Iain Gray said, “These programmes not only help build and strengthen links between countries but will help build the international partnerships between businesses so vital in today’s global economy.”

The Programme of Co-operation is expected to expand further over a period of time, for the mutual benefit of businesses from both countries.

Latest stories

Related stories

Quantum Computing Advances Make Way for Lifesaving Therapies

The fact is that there is something very profoundly...

Resistance-Evasive Antibiotic for Genes-Free Clinics

In a startling figure, multidrug-resistant bacteria kill almost 5...

Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma

In order to treat multiple myeloma in adults, Sarclisa...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back